See also this year's filing and all EDGAR filings for this company.
PDF Report 0001052284_2012_Tongli_Pharmaceuticals_USA_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001052284, Tongli Pharmaceuticals USA Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,978,646 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,383,717 |
| 3 | remainder_Assets | 7,504,409 |
| 4 | LiabilitiesCurrent | 1,790,763 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 613,611 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 9,723,334 |
| 11 | remainder_Revenues | 14,655,239 |
| 12 | remainder_NetIncome | -58,225 |
| 13 | remainder_ComprehensiveNetIncome | 562,020 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,866,772 |
| 1 | Liabilities | 1,790,763 |
| 2 | Expenses | 10,336,945 |
| 3 | Revenues | 14,655,239 |
| 4 | StockholdersEquity | 16,076,009 |
| 5 | NetIncome | 4,260,069 |
| 6 | ComprehensiveNetIncome | 4,541,079 |
| 7 | BaseVar | 22,634,982 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.03 |
| 9 | EconomicCapitalRatio | 4.41 |
Edgar->Model Mapping
Feature Distribution
